Real-time enrollment status for this neuromyelitis optica spectrum disorder clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 6:32 AM UTC
| NCT Number | NCT05966467 |
| Recruiting Status | Recruiting |
| Condition | Neuromyelitis Optica Spectrum Disorder |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Alexion Pharmaceuticals, Inc. |
| Last Updated on CT.gov | October 13, 2026 (2 days ago) |
As of October 15, 2026: Clinical trial NCT05966467 is currently recruiting participants. This clinical trial study for neuromyelitis optica spectrum disorder is actively seeking new participants at 6 locations across the United States. The study is sponsored by Alexion Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05966467 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05966467 was last updated 2 days ago (October 13, 2026). HelloStudys verifies this status automatically.